@article{698308cfd8804d4f8868254c9234b229,
title = "Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization (Cancer Chemotherapy and Pharmacology, (2017), 80, 6, (1171-1178), 10.1007/s00280-017-3463-x)",
abstract = "In the original publication of the article, the second author name has been misspelled.",
author = "Verheijen, {R. B.} and Swart, {E. L.} and Beijnen, {J. H.} and Schellens, {J. H.M.} and Huitema, {A. D.R.} and N. Steeghs",
note = "Publisher Copyright: {\textcopyright} 2020, Springer-Verlag GmbH Germany, part of Springer Nature.",
year = "2020",
month = jul,
day = "1",
doi = "10.1007/s00280-020-04090-4",
language = "English",
volume = "86",
pages = "163",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
number = "1",
}